Hormetic responses of thyroid hormone calorigenesis in the liver: Association with oxidative stress

IUBMB Life

Volumn 62, Issue 6, 2010, Pages 460-466

  Videla, Luis A ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Hormesis; Kupffer cell; Liver; Oxidative stress; Redox upregulation of gene expression; Thyroid hormone

Indexed keywords

FIBRINOGEN; HAPTOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; THYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVITY; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HORMESIS; HYPERTHYROIDISM; ISCHEMIC PRECONDITIONING; KUPFFER CELL; LIVER; LIVER CELL; LIVER TRANSPLANTATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION; THERMOGENESIS; TRANSCRIPTION INITIATION; UPREGULATION;

ENERGY METABOLISM; HUMANS; LIVER; OXIDATIVE STRESS; THYROID HORMONES;

EID: 77953573806     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.345     Document Type: Review

References (101)

1. Calabrese, E. J. (2008) Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law manifestations of hormesis. Ageing Res. Rev. 7, 8-20.
2. Rattan, S. I. S. (2008) Hormesis in aging. Ageing Res. Rev. 7, 63-78.
3. Masoro, E. J. (2007) The role of hormesis in life extension by dietary restriction. Interdiscip. Top. Gerontol. 35, 1-17.
4. Goto, S., Naito, H., Kaneko, T., Chung, H. Y., and Radák, Z. (2007) Hormetic effects of regular exercise in aging: correlation with oxidative stress. Appl. Physiol. Nutr. Metab. 32, 948-953.
5. Calabrese, E. J. and Blain, R. (2004) The hormetic database: an overview. Toxicol. Appl. Pharmacol. 202, 289-300.
6. Calabrese, E. J. and Baldwin, L. A. (2001) The frequency of U-shape dose responses in the toxicology literature. Toxicol. Sci. 62, 330-338.
7. Sies, H. (1991) Oxidative stress: from basic research to clinical application. Am. J. Med. 91, 31S-38S.
8. Dr̈ge, W. (2002) Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
9. Martindale, J. L. and Holbrook, N. J. (2002) Cellular responses to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.
10. Poli, G., Leonarduzzi, G., Biasi, F., and Chiarpotto, E. (2004) Oxidative stress and cell signaling. Curr. Med. Chem. 11, 1163-1182.
11. Boveris, A., Repetto, M. G., Bustamante, J., Boveris, A. D., and Valdez, L. B. (2008) The concept of oxidative stress in pathology. In Free Radical Pathophysiology (Alvarez, S. andEvelson, P., eds.). pp. 1-17, Transworld Research Network, Kerala, India.
12. Videla, L. A., Fernández, V., Tapia, G., and Varela, P. (2007) Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front. Biosci. 12, 1220-1228.
13. Janssen-Heininger, Y. M., Mossman, B. T., Heintz, N. H., Forman, H. J., Kalyanaraman, B., Finkel, T., Stamler, J. S., Rhee, S. G., and van der Vliet, A. (2008) Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic. Biol. Med. 45, 1-17.
14. Massip-Salcedo, M., Rosello-Catafau, J., Prieto, J., Avila, M. A., and Peralta, C. The response of the hepatocyte to ischemia. Liver Int. 27, 6-16.
15. Videla, L. A. (2009) Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J. Hepatol. 1, 73-79.
16. Yen, P. M. (2001) Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81, 1097-1142.
17. Duncan Bassett, J. H., Harvey, C. B., and Williams, G. R. (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 213, 1-11.
18. Weitzel, J. M., Radtke, C., and Seitz, H. J. (2001) Two thyroid hormone- mediated gene expression patterns in vivo identified by cDNA expression arrays in rat. Nucleic Acids Res. 29, 5148-5155.
19. Davis, P. J., Leonard, J. L., and Davis, F. B. (2008) Mechanisms of nongenomic actions of thyroid hormone. Front. Neuroendocrinol. 29, 211-218.
20. Silvestri, E., Burrone, L., de Lange P., Lombarda, A., Farina, P., Chambery, A., Parente, A., Lanni, A., Goglia, F., and Moreno, M. (2007) Thyroid-state influence on protein-expression profile of rat skeletal muscle. J. Proteome Res. 6, 3187-3196.
21. Arnold, S., Goglia, F., and Kadenbach, B. (1998) 3,5-Diiodothyronine binds to subunit Va of cytochrome c oxidase and abolishes the allosteric inhibition of respiration by ATP. Eur. J. Biochem. 252, 325-330.
22. Fernández, V., Barrientos, X., Kipreos, K., Valenzuela, A., and Videla, L. A. (1985) Superoxide radical generation, NADPH oxidase activity, and cytochrome P450 content in an experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 117, 496-501.
23. Lanni, A., Moreno, M., Lombardi, A., and Goglia, F. (2003) Thyroid hormone and uncoupling proteins. FEBS Lett. 543, 5-10.
24. Soboll, S. (1993) Thyroid hormone action on mitochondrial energy transfer. Biochim. Biophys. Acta 1144, 1-16.
25. Fernández, V. and Videla, L. A. (1993) Influence of hyperthyroidism on superoxide radical and hydrogen peroxide production by rat liver submitochondrial particles. Free Radic. Res. Commun. 18, 329-335.
26. 2 production by rat liver mitochondria. Mol. Cell. Endocrinol. 205, 185-192. (Pubitemid 37297364)
27. Fernández, V., Massa, L., Quiñones, L., Simon-Giavarotti, K. A., Giavarotti, L., D'Almeyda, V., Azzalis, L.A, Junqueira, V. B. C., and Videla, L. A. (2003) Effects of γ-hexachlorocyclohexane and L-3,30,5- triiodothyronine on rat liver cytochrome P4502E1-dependent activity and content in relation to microsomal superoxide radical generation. Biol. Res. 36, 359-365.
28. Huh, K., Kwon, T. H., Kim, J. S., and Park, J. M. (1998) Role of the hepatic xanthine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver. Arch. Pharm. Res. 21, 236-240.
29. Tapia, G., Pepper, I., Smok, G., and Videla, L. A. (1997) Kupffer cell function in thyroid hormone-induced liver oxidative stress. Free Radic. Res. 26, 267-279.
30. Voci, A., Demori, I., Franzi, A. T., Fugassa, E., Goglia, F., and Lanni, A. (2001) Uncoupling protein 2 mRNA expression and respiratory parameters in Kupffer cells isolated from euthyroid and hyperthyroid rat livers. Eur. J. Endocrinol. 145, 317-322.
31. Asayama, K., Dobashi, K., Hayashibe, H., Megata, Y., and Kato, K. (1987) Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 121, 2112-2118.
32. Sir, T., Wolff, C., Soto, J. R., Perez, G., and Armas-Merino, R. (1987) Relationship between hepatic levels of glutathione and sulphobromophthalein retention in hyperthyroidism. Clin. Sci. 73, 235-237.
33. Simon-Giavarotti, K. A., Rodrigues, L., Rodrigues, T., Junqueira, V. B. C., and Videla, L. A. (1998) Liver microsomal parameters related to oxidative stress and antioxidant systems in hyperthyroid rats subjected to acute lindane treatment. Free Radic. Res. 29, 35-42.
34. Venditti, P., Balestrieri, M., Di Meo, S., and De Leo, T. (1997) Effect of thyroid state on lipid peroxidation, antioxidant defenses, and susceptibility to oxidative stress in rat tissues. J. Endocrinol. 155, 151-157.
35. Landriscina, C., Petragallo, V., Morini, P., and Marcotrigiano, G. O. (1988) Lipid peroxidation in rat liver microsomes. I. Stimulation of the NADPH-cytochrome P450 reductase-dependent process in hyperthyroid state. Biochem. Int. 17, 385-393.
36. Fernández, V. and Videla, L. A. (1996) Effect of hyperthyroidism on the biliary release of thiobarbituric acid reactants in the rat. Toxicol. Lett. 84, 149-153.
37. Tapia, G., Cornejo, P., Fernández, V., and Videla, L. A. (1999) Protein oxidation in thyroid hormone-induced liver oxidative stress: relation to lipid peroxidation. Toxicol. Lett. 106, 209-214.
38. Andican, G., Gelisgen, R., Civelek, S., Seven, A., Seymen, O., Altug, T., Yigit, G., and Burcak, G. (2004) Oxidative damage to nuclear DNA in hyperthyroid rat liver: inability of vitamin C to prevent the damage. J. Toxicol. Environ. Health 67, 413-420.
39. Gomez, L. F., Lorente, S., Simon-Giavarotti, K. A., Areco, K. N., Araújo-Peres, C., and Videla, L. A. (2004) Tri-iodothyronine differentially induces Kupffer cell ED1/ED2 subpopulations. Mol. Aspects Med. 25, 183-190.
40. Videla, L. A., Sir, T., and Wolff, C. (1988) Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radic. Res. Commun. 5, 1-10.
41. Ademoglu, E., Gokkusu, C., Yarman, S., and Azizlerli, H. (1998) The effect of methimazole on the oxidant and antioxidant system in patients with hyperthyroidism. Pharmacol. Res. 38, 93-96.
42. Adali, M., Inal-Erden, M., Akalin, A., and Efe, B. (1999) Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin. Biochem. 32, 363-367.
43. Seven, A., Tasan, E., Inci, F., Hatemi, H., and Burcak, G. (1998) Biochemical evaluation of oxidative stress in propylthiouracil treated hyperthyroid patients. Effects of vitamin C supplementation. Clin. Chem. Lab. Med. 36, 767-770.
44. Bianchi, G., Solaroli, E., Zaccheroni, V., Grossi, G., Bargossi, A. M., Melchionda, N., and Marchesini, G. (1999) Oxidative stress and antioxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm. Metab. Res. 31, 620-624.
45. Sewerynek, J., Wiktorska, J., Nowak, D., and Lewinski, A. (2000). Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr. Regul. 34, 83-89.
46. Komosinska-Vessev, K., Olczyk, K., Kucharz, E. J., Marcisz, C., Winsz-Szczotka, K., and Kotulska, A. (2000) Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin. Chim. Acta 300, 107-117.
47. Guerra, L. N., Moiguer, S., Karner, M., de Molina, M. C., Sreider, C. M., and Burdman, J. A. (2001) Antioxidants in the treatment of Graves disease. IUBMB Life 51, 105-109.
48. Yavuz, D. G., Yuksel, M., Deyneli, O., Ozen, Y., Aydin, H., and Akalin, S. (2004) Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goiter patients. Clin. Endocrinol. 61, 515-521.
49. Bednarek, J., Wysocki, H., and Sowinski, J. (2004) Oxidation products and antioxidant markers in plasma of patients with Graves, disease and toxic multinodular goiter: effect of methimazole treatment. Free Radic. Res. 38, 659-664.
50. Wilson, R., Chopra, M., Bradley, H., McKillop, J. H., Smith, W. E., and Thomson, J. A. (1989) Free radicals and Graves, disease: the effect of therapy. Clin. Endocrinol. 30, 429-433.
51. Lissi, E. A., Salim-Hanna, M., Sir, T., and Videla, L. A. (1992) Is spontaneous urinary visible chemiluminescence a reflection of in vivo oxidative stress? Free Radic. Biol. Med. 12, 317-322.
52. Bilzer, M., Roggel, F., and Gerbes, A. L. (2006) Role of Kupffer cells host defense and liver disease. Liver Int. 26, 1175-1186.
53. Kolios, G., Valatas, V., and Kouroumalis, E. (2006) Role of Kupffer cells in the pathogenesis of liver disease. World J. Gastroenterol. 12, 7413-7420.
54. Su, G. L. (2002) Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G256-G265.
55. Kaisho, T. and Akira, S. (2006) Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117, 979-987.
56. Gloire, G., Legrand-Poels, S., and Piette, J. (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493-1505.
57. Kabe, Y., Ando, K., Hirao, S., Yoshida, M., and Handa, H. (2005) Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7, 395-403.
58. Tran-Thi, T. A., Decker, K., and Baeuerle, P. A. (1995) Differential activation of transcription factors NF-κB and AP-1 in rat liver macrophages. Hepatology 22, 613-619.
59. Babior, B. M., Lambeth, J. D., and Nauseef, W. (2002) The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344.
60. Vrba, J. and Modriansky, M. (2002) Oxidative burst of Kupffer cells: target for liver injury treatment. Biomed. Pap. 146, 15-20.
61. Francavilla, A., Carr, B. I., Azzarone, A., Polimeno, L., Wang, Z., Van Thiel, D. H., Subbotin, V., Prelish, J. G., and Starzi, T. E. (1994) Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 20, 1237-1241.
62. Columbano, A. and Shinozuko, H. (1996) Liver regeneration versus direct hyperplasia. FASEB J. 10, 1118-1128.
63. Hardonk, M. J., Dijkhuis, F. W. J., Hultaert, C. E., and Koudstaal, J. (1992) Heterogeneity of rat liver and spleen macrophages in gadolinium chloride elimination and repopulation. J. Leukoc. Biol. 52, 296-302.
64. Sellitti, D. F., Oliver, C., and Latham, K. R. (1985) Antibodies to nuclear thyroid hormone-binding proteins. Antibody characterization and immunofluorescent localization. Exp. Cell Res. 158, 223-236.
65. Fernández, V., Videla, L. A., Tapia, G., and Israel, Y. (2002) Increases in tumor necrosis factor-a in response to thyroid hormoneinduced liver oxidative stress in the rat. Free Radic. Res. 36, 719-725.
66. Tapia, G., Fernández, V., Varela, P., Cornejo, P., Guerrero, J., and Videla, L. A. (2003) Thyroid hormone-induced oxidative stress triggers nuclear factor-κB activation and cytokine gene expression in rat liver. Free Radic. Biol. Med. 35, 257-265.
67. Tapia, G., Fernández, V., Pino, C., Ardiles, R., and Videla, L. A. (2006) The acute-phase response of the liver in relation to thyroid hormone-induced redox signaling. Free Radic. Biol. Med. 40, 1628-1635.
68. Fernández, V., Reyes, S., Bravo, S., Sepúlveda, R., Romanque, P., Santander, G., Castillo, I., Varela, P., Tapia, G., and Videla, L. A. (2007) Involvement of Kupffer cell-dependent signaling in T3-induced hepatocyte proliferation in vivo. Biol. Chem. 388, 831-837.
69. Fernández, V., Tapia, G., Varela, P., and Videla, L. A. (2005) Redox regulation of thyroid hormone-induced Kupffer cell-dependent IκB-α phosphorylation in relation to inducible nitric oxide synthase expression. Free Radic. Res. 39, 411-418.
70. Fernández, V., Tapia, G., Varela, P., Cornejo, P., and Videla, L. A. (2009) Upregulation of liver inducible nitric oxide synthase following HORMESIS UNDERLYING THYROID HORMONE ACTION 465 thyroid hormone preconditioning: suppression by N-acetylcysteine. Biol. Res. 42, 487-497.
71. Fernández, V., Tapia, G., Varela, P., Castillo, I., Mora, C., Moya, F., Orellana, M., and Videla, L. A. (2005) Redox up-regulated expression of rat liver manganese superoxide dismutase and Bcl-2 by thyroid hormone is associated with inhibitor of κB-α phosphorylation and nuclear factor-κB activation. J. Endocrinol. 186, 539-547.
72. Griffin, E. E. and Miller, L. L. (1973) Effects of hypothyroidism, hyperthyroidism, and thyroxine on net synthesis of plasma proteins by the isolated perfused rat liver. J. Biol. Chem. 248, 4716-4723.
73. Fitch, C. A., Song, Y., and Leverson, C. W. (1999) Developmental regulation of hepatic ceruloplasmin mRNA and serum activity by exogenous thyroxine and dexamethasone. Proc. Soc. Exp. Biol. Med. 221, 27-31.
74. Lin, K. H., Lee, H. Y., Shih, C. H., Yen, C. C., Yang, R. C., and Wang, C. S. (2003) Plasma protein regulation by thyroid hormone. J. Endocrinol. 179, 367-377.
75. Leedman, P. J., Stein, A. R., Chin, W. W., and Rogers, J. T. (1996) Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J. Biol. Chem. 271, 12017-12023.
76. Gruys, E., Toussaint, M. J. M., Niewold, T. A., and Koopmans, S. J. (2005) Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B 6, 1045-1056.
77. Fausto, N., Campbell, J. S., and Riehle, K. J. (2006) Liver regeneration. Hepatology 43, S45-S53.
78. Fernández, V., Castillo, I., Tapia, G., Romanque, P., Uribe-Echevarría, S., Uribe, M., Cartier-Ugarte, D., Santander, G., Vial, M. T., and Videla, L. A. (2007) Thyroid hormone preconditioning: protection against ischemiareperfusion liver injury in the rat. Hepatology 45, 170-177.
79. Kamada, H., Honda S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005) Reactive oxygen species promote TNFa-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
80. Fernández, V., Tapia, G., Varela, P., Gaete, L., Vera, G., Mora, C., Vial, M. T., and Videla, L. A. (2007) Causal role of oxidative stress in liver preconditioning by thyroid hormone in rats. Free Radic. Biol. Med. 44, 1724-1731.
81. Goglia, F. and Skulachev, V. P. (2003) A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to outer membrane leaflet. FASEB J. 17, 1585-1591.
82. Grant, N. (2007) The role of triiodothyronine-induced substrate cycles in the response to overnutrition: thyroid hormone as an antioxidant. Med. Hypotheses 68, 641-648.
83. Kobayashi, M. and Yamamoto, M. (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signal. 7, 385-394.
84. Zhang, Q., Pi, J., Woods, C. G., and Andersen, M. E. (2009) Phase I and II cross-induction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses. Toxicol. Appl. Pharmacol. 237, 345-356.
85. Bassett, J. H. D., Harvey, C. B., and Williams, G. R. (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 213, 1-11.
86. Mezosi, E., Szabo, J., Nagy, E. V., Borbely, A., Varga, E., Paragh, G., and Varga, Z. (2005) Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J. Endocrinol. 185, 121-129.
87. 3 itself? Endocrinology 143, 504-510.
88. 31P-NMR study. Circ. Res. 66, 735-746.
89. Pantos, C., Mourouzis, I., and Cokkinos, D. V. (2010) Thyroid hormones as a therapeutic option for treatment ischaemic heart disease: from early reperfusion to late remodelling. Vasc. Pharmacol. 52, 157-165.
90. Pantos, C. I., Malliopoulou, V. A., Mourouzis, I. S., Karamanoli, E. P., Paizis, I. A., Steimberg, H., Varonos, D. D., and Cokkinos, D. V. (2002) Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid 12, 325-329.
91. Casillas-Ramírez, A., Mosbah, I. B., Ramalho, F., Roselló-Catafau, J., and Peralta, C. (2006) Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 79, 1881-1894.
92. Clavien, P. A., Selzner, M., Rüdiger, H. A., Graf, R., Kadry, Z., Rousson, V., and Jochum, W. (2003) A prospective randomized study in 100 consecutive patients undergoing major liver resection performed with versus without ischemic preconditioning. Ann. Surg. 238, 843-852.
93. Smyrmiotis, V., Theodoraki, K., Arkadopoulos, N., Fragulidis, G., Condi-Pafiti, A., Plemerou-Fragou, M., Vassiliou, J., and Dimakakos, P. (2006) Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study. Am. J. Surg. 192, 669-674.
94. Heizmann, O., Loehe, F., Volk, A., and Schauer, R. J. (2008) Ischemic preconditioning improves postoperative outcome after liver resections: a randomized controlled study. Eur. J. Med. Res. 13, 79-86.
95. Totsuka, E., Fung, J. J., Urakami, A., Moras, N., Ishii, T., Takahashi, K., Narumi, S., Hakamada, K., and Sasaki, M. (2000) Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 31, 577-580.
96. Barrier, A., Olaya, N., Chiappinia, F., Roser, F., Scatton, O., Artus, C., Franc, B., Dudoit, S., Flahault, A., Debuire, B., Azoulay, D., and Lemoine, A. (2005) Ischemic preconditioning modulates the expression of several genes, lading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion. FASEB J. 19, 1617-1626.
97. Amador, A., Grande, L., Martí, J., Deulofeu, R., Miquel, R., Solá, A., Rodríguez-Laiz, G., Ferrer, J., Fondevila, C., Charco, R., Fuster, J., Hotter, G., and García-Valdecasas, J. C. (2007) Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am. J. Transplant. 7, 2180-2189. (Pubitemid 47247061)
98. Koneru, B., Fisher, A., He, Y., Klein, K. M., Skurnick, J., Wilson, D. J., de la Torre, A. N., Merchant, A., Arora, R., and Samanta, A. K. (2005) Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transplant. 11, 196-202.
99. Azoulay, D., Lucidi, V., Andreani, P., Maggi, U., Sebagh, M., Ichai, P., Lemoine, A., Adam, R., and Castaing, D. (2006) Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J. Am. Coll. Surg. 202, 203-211.
100. Rahbari, N. N., Wente, M. N., Schemmer, P., Diener, M. K., Hoffmann, K., Motschall, E., Schmidt, J., Weitz, J., and Büchler, M. W. (2008) Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br. J. Surg. 95, 424-432.
101. Brent, G. and Larsen, P. R. (1996) Treatment of hypothyroidism. In Werner and Ingbar's The Thyroid (Braverman, L. E. and Utiger, R. D., eds.). pp. 883-887, Lippincott-Raven Publishers, Philadelphia.